Why Purchasing expensive .bond domain is indicator of reputable institution

Reputability is everything when it comes to financial decisions and investment.

You can think of your reputation as a form of currency; businesses without a solid reputation will quickly find their cash flow dwindling.

No matter the size of your company, you should be making a point to be thinking about your presence online. As we increasingly live our lives online, we have to ensure that the first impression counts while remembering that last impressions are forever.

Registering a .BOND domain name could be the first step towards your digital success.

If you are a financial institution, such as a bank, a trust, an insurance company a brokerage firm, or and investment dealer, then you are engaged in the business of dealing with financial and monetary transactions encompassing a broad range of business operations within the financial services sector.

Making decisions about domain extensions and cybersecurity typically aren’t part of the daily business. However, that doesn’t mean that they are any less important for long-term success.

An important aspect of a proactive branding strategy and establishing a trustworthy online presence is your domain name. But the name itself is only part of the deal; you also have to determine which

Read More

Goldilocks year awaits emerging markets defying Covid-19 pandemic rout

Emerging-market seem to have everything going for them right now, with the November rally offering a hint of what 2021 may have in store.

A plethora of tailwinds from accommodative to an impending change of U.S. president and Covid-19 vaccine progress has put the assets of developing nations on course for some impressive milestones. Bonds have wiped out their year-to-date losses, while MSCI Inc.’s currency index is poised for the best month since January 2019 as well as a second successive annual gain. The MSCI stocks gauge is on track for its best month since March 2016.

Underpinning the recovery is a resurgence in foreign-investor interest. Fourth-quarter portfolio inflows to are poised to hit the highest in eight years, data from the Institute of International Finance show. Yet, for all the euphoria, foreign positioning in bonds and equities for developing nations excluding China remains light, and Deutsche Bank AG’s Sameer Goel, says the rally is far from over.

“It’s Goldilocks for emerging markets’ under-invested assets as we go into 2021,” said Goel, the bank’s head of macro research in Singapore. They “have

Read More

VC investments in online gaming start-ups hike 114% to $376 mn in 2020

gained speed during the lockdown phase and the month-on-month traffic is still increasing, attracting investors.

According to Venture Intelligence data, venture capital rose by around 114 per cent this year to $376 million (January to date) from $176 million in 2019 (full year). Investors say the industry presents the next multi-billion dollar opportunity for and enterprises, especially after the ban on Chinese apps.

According to reports, have risen up to 275 in 2019, which is a huge increase considering there were only 25 such in 2010.


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

Read More

US Predicts ‘Vaccines Before Christmas’ As Virus Super-surge Looms

Hopes for a first wave of vaccinations before the end of 2020 received a boost with US firm Moderna saying it was filing Monday for emergency authorization of its Covid-19 vaccine in the United States and Europe.

After top US scientists warned Americans to brace for a “surge superimposed on the surge,” Moderna reported full results had confirmed a high efficacy estimated at 94.1 percent.

The first of Moderna’s two doses could be injected into the arms of millions of Americans by the middle of December

It was set to join American pharmaceutical maker Pfizer and Germany’s BioNTech, which applied for similar approvals last week, and have predicted their vaccine could be greenlit in the US shortly after December 10.

If the US Food and Drug Administration agrees Moderna’s product is safe and effective, the first of the drug’s two doses could be injected into the arms of millions of Americans by the middle of December.

How Moderna's vaccine uses genetic information from SARS-CoV-2 to stimulate the body's immune response. Moderna said it would file requests for use of its vaccine in the US and Europe on November 30

How Moderna’s vaccine uses genetic information from SARS-CoV-2 to stimulate the body’s immune response. Moderna said it would file requests for use of its vaccine in the US and Europe on November 30

“We believe that

Read More